ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ: ZYBT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.92
+5.75% today
Updated 2026-04-30
Market cap
$43.72M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $14
Volume
0.3M
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.92
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -12.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.